Clinical Decision Support Tools Can Help Doctors Quickly

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Clinical Decision Support Tools Can Help Doctors Quickly and Accurately Diagnose Ebola and Other Infectious Diseases

ROCHESTER, N.Y., Oct. 3, 2014 (GLOBE NEWSWIRE) -- Four years ago, the Institute of Medicine recommended the Department of Health and Human Services promote the use of clinical decision support tools to ensure doctors quickly and accurately detect and diagnose bioterrorism and infectious disease outbreaks.

Today, with the threat of Ebola and other deadly diseases arriving via airplane in the U.S., most hospital emergency departments still don't have these tools, even though they're readily available, affordable and proven effective.

"Diagnosing a disease they've never seen before can be difficult for physicians, especially if they fail to take note of a patient's travel history, and they're working in a busy emergency department," said Art Papier, MD, CEO and co-founder of Logical Images, the company that created VisualDx , a clinical decision support tool used by thousands of doctors to accurately diagnose and treat disease. "A clinical decision support tool will help physicians quickly and accurately diagnose disease by ensuring their patients' international travel history is recorded and their symptoms are compared against a database of diseases prevalent in the countries where the patients traveled."

In the first case of Ebola virus disease reported in the U.S., the patient who had traveled from Liberia was not accurately diagnosed in his first visit to the emergency department. He left the hospital and potentially exposed family members to the deadly virus before he was accurately diagnosed and quarantined.

With VisualDx, an app and online clinical decision support system, the physician is taken through a series of questions, including questions about recent travel, symptoms, medication, lab results and any visual signs of disease. VisualDx then uses a patented process to quickly deliver "stacked visual knowledge" – a highly specific list of potential diagnoses, a series of medical images to compare to the patient's current conditions and the recommended treatments.

Doctors then use VisualDx to arrive at the best diagnosis, explain the process to the patient using the images and decide on the right treatment for each unique patient.

"With VisualDx, public health alerts and clinical guidelines can be made available within 24 hours of an outbreak, natural disaster, contamination or other events that require an immediate or coordinated medical response," said Dr. Papier. "We know it works because more than 1,500 hospitals and large clinics, including the U.S. Department of Veterans Affairs, rely on VisualDx to help them quickly and accurately diagnose disease and educate their patients."

VisualDx is available directly on the web, integrated into Electronic Medical Records (EMR) and as a mobile app that works with the iPhone, Android and iPad.

To see a video regarding VisualDx please visit: http://www.visualdx.com/visualdx-videos/

To see a version of this app for consumers, please visit: www.skinsight.com

About Logical Images

Logical Images, based in Rochester, NY, is the industry leader in visual diagnostic decision support, providing affordable, fast and widely used mobile apps and online resources scientifically proven to improve diagnostic accuracy while also educating and empowering patients. The company's products include VisualDx (VisualDx.com), a mobile app and online clinical decision support system for diagnostic accuracy , and Skinsight (Skinsight.com), the Web's leading consumer skin health and wellness resource.

Media Contact: Laura Mecoy 310-546-5860

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 183

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading